Reuters logo
BRIEF-Iovance Biotherapeutics reports Q3 GAAP loss per share $0.35
2017年10月31日 / 晚上9点17分 / 22 天前

BRIEF-Iovance Biotherapeutics reports Q3 GAAP loss per share $0.35

Oct 31 (Reuters) - Iovance Biotherapeutics Inc

* Iovance Biotherapeutics Inc reports third quarter 2017 financial results

* Q3 non-GAAP loss per share $0.31

* Q3 GAAP loss per share $0.35

* Q3 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S

* Iovance Biotherapeutics Inc - ‍anticipates cash, cash equivalents and short-term investments as of December 31, 2017, to be in excess of $141.0 million​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below